The novel kind of cancer immunotherapy known as chimeric antigen receptor (CAR) T-cell treatment has prompted the US Food and Drug Administration (FDA) to announce an investigation into the potential…
Home » Secondary Cancer
The novel kind of cancer immunotherapy known as chimeric antigen receptor (CAR) T-cell treatment has prompted the US Food and Drug Administration (FDA) to announce an investigation into the potential…